Granger to Tour Healthpoint Biotherapeutics

Sep 6, 2013 Issues: Health Care

Congresswoman Kay Granger today will tour Healthpoint Biotherapeutics, a business of Smith & Nephew, to see the company’s newly expanded cell therapy research and manufacturing facility.  

“Biologics are a critical part of modern medicine and here in Fort Worth, Healthpoint Biotherapeutics is on the cutting edge,” said Rep. Granger.  “The employees at Healthpoint are the best of the best, developing new, innovative products that help patients recover.  I am dedicated to ensuring unnecessary regulations and misguided policies don’t interfere with the growth of companies like Healthpoint.”

Today’s tour is one in a series of tours that Rep. Granger is participating in this month across the 12th district.  Employing more than 150 individuals in Fort Worth, Healthpoint Biotherapeutics is a biopharmaceutical company that develops innovative solutions for wound care. With a recent expansion, the Healthpoint Biotherapeutics cell therapy research and manufacturing facility has over 80,000 square feet of space, which includes manufacturing infrastructure, research and testing labs, and ‘clean room’ space for the production of cell-based therapies.

“We are excited to have Rep. Granger visit our facility today,” said Robert E. Bancroft, President of Healthpoint Biotherapeutics.  “From research to manufacturing to sales and marketing, our business model, products, and, ultimately, patients, are heavily impacted by what happens in Washington.  We are very pleased to have a leader in Congress, like Rep. Granger, who is committed to medical research, economic growth, and our community.”